Data from the STEP 1 trial showed that participants who discontinued semaglutide after 68 weeks regained approximately two-thirds of their lost weight within a year of stopping
After 48 weeks, the 4 mg retatrutide group led to weight reductions of more than 5%, 10%, and 15% in 92%, 75%, and 60% of participants, respectively
Their injuries included rotator cuff damage, bursitis, cartilage tears, joint instability, calcium buildup, and worn-out tendons
Peptides sitting in hot delivery vehicles or on sun-exposed porches can experience temperature excursions that compromise stability
Meanwhile, encapsulated metformin maintains prolonged hypoglycemia (50% release of metformin was reached within 30 h)